Novavax clarifies it has not updated FY2024 guidance after analyst report

NOVAVAX INC

Analyst report published Oct 1, 2024 cited management discussions on US COVID-19 vaccine market.
Novavax has not updated or reaffirmed its full year 2024 guidance issued August 8, 2024.
Company expects US COVID-19 vaccination market for 2024-2025 season to be similar to last year.
No change to previously issued FY2024 guidance; no new financial information provided.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.